This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aduro Biotech Holdings, Europe B.v.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Winfried Robert Mulder: A Notable Inventor in the Biotech Field
Introduction: Winfried Robert Mulder, an accomplished inventor based in Oss, Netherlands, has made significant contributions to the field of biotechnology. His innovative work has led to the development of a patent that enhances the understanding of human CD27, a critical protein in immune response and cancer therapy.
Latest Patents: Mulder holds a patent for an agonistic antibody to CD27. This invention pertains to a binding compound that targets the same epitope of human CD27 as the monoclonal antibody hCD27.15. This antibody was produced by the hybridoma hCD27.15, which was deposited with the American Type Culture Collection (ATCC) on June 2, 2010, under number PTA-11008. The patent further details the composition of the antibody, which may include specific heavy and light chain variable regions that comprise at least one complementary-determining region (CDR) selected from designated operational identifiers.
Career Highlights: Winfried Robert Mulder is currently associated with Aduro Biotech Holdings, Europe B.V., where he continues to advance research in immunology and therapeutic applications. His expertise in antibody engineering positions him as a key figure in the development of novel treatment strategies aimed at enhancing immune response against diseases, particularly cancers.
Collaborations: Throughout his career, Mulder has worked alongside notable colleagues such as Hans Van Eenennaam and Jannetje Geertruida Borst. These collaborations foster an environment of innovation and knowledge sharing, contributing to significant breakthroughs in the biotech industry.
Conclusion: Winfried Robert Mulder exemplifies the spirit of innovation in biotechnology with his patent for the agonistic antibody to CD27. His commitment to advancing science through meaningful research and collaboration highlights the impactful role of inventors in improving healthcare solutions. Mulder's impressive accomplishments and ongoing work promise to contribute significantly to the future of immunotherapy and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile